ATMLP regulates MDVs mediated inflammation induced by radiotherapy in lung cancer
Journal of Radiation Research · 05.11.2026
DOI: 10.1093/jrr/rrag092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Radiation Research, online erschienen am 05.11.2026. Verfasst von Jie Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Suzhou Medical College of Soochow University,…. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New Round of Xuzhou 'Pengcheng Talent Program'-High-level Healthcare Talent Recruitment and Development Project, National Natural Science Foundation of China, New Round of Xuzhou ‘Pengcheng Talent Program’—High-level Healthcare Talent Recruitment and Development Project.
Abstract (Originalsprache)
Lung cancer is the leading cause of cancer-related deaths worldwide, and radiotherapy, a commonly used treatment for lung cancer, is associated with a variety of complications while treating cancer, among which radiotherapy-induced pneumonia is a common complication whose underlying mechanism remains unclear and requires further investigation. To address this, cell lines with ATMLP overexpression and knockdown were created using gene editing techniques, and Western blot, immunofluorescence and trans-well co-culture were used to explore the role of mitochondria-derived vesicles (MDVs) in mediating radiotherapy-induced inflammation, as well as the effects of ATMLP, DRP-1 and PGAM5 on MDVs. Ionizing radiation promoted the expression of ATMLP and the release of ATMLP-mediated MDVs. Up-regulation of ATMLP expression led to increased levels of PGAM5 and activation of phosphorylation at the Ser616 site of DRP-1. The increased number of MDVs further promoted macrophage polarization toward the M1 phenotype. Overall, ionizing radiation induces ATMLP expression, which enhances MDVs release through the PGAM5/DRP-1 axis. This process leads to macrophage polarization toward the M1 phenotype, contributing to the inflammatory response.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Suzhou Medical College of Soochow University, 199 Ren'ai Road, Suzhou 215123, China.
- Department of Radiation Oncology, Xuzhou Central Hospital, Southeast University, 199 Jiefang South Road, Xuzhou 221000, China.
- Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, No. 1 Banshan East Road, Hangzhou 310022, China.
ORCID-Profile: Jie Lu
Förderung
- New Round of Xuzhou 'Pengcheng Talent Program'-High-level Healthcare Talent Recruitment and Development Project
- National Natural Science Foundation of China
- New Round of Xuzhou ‘Pengcheng Talent Program’—High-level Healthcare Talent Recruitment and Development Project
Zitieren
APA
Lu, J., Zhang, A., Feng, Q., Xu, J., Liu, J., Zhou, Y., Li, W., & Pei, H. (2026). ATMLP regulates MDVs mediated inflammation induced by radiotherapy in lung cancer. Journal of Radiation Research. https://doi.org/10.1093/jrr/rrag092
Vancouver
Lu J, Zhang A, Feng Q, Xu J, Liu J, Zhou Y, et al. ATMLP regulates MDVs mediated inflammation induced by radiotherapy in lung cancer. Journal of Radiation Research. 2026. doi:10.1093/jrr/rrag092
BibTeX
@article{Lu2026,
author = {Lu, Jie and Zhang, Aiyue and Feng, Qiong and Xu, Jinyang and Liu, Jiyuan and Zhou, Yun and Li, Wanshi and Pei, Hailong},
title = {ATMLP regulates MDVs mediated inflammation induced by radiotherapy in lung cancer},
journal = {Journal of Radiation Research},
year = {2026},
doi = {10.1093/jrr/rrag092}
}
EUVIMED